Researchers at the Spanish National Research Council (CSIC) Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) have discovered and synthesized a number of molecules that inhibit the effects of ...

In a recent study posted to the bioRxiv* preprint server, researchers performed an extensive library docking for new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) ...

The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstrated ability to "cure" previously lethal blood cancers.

Matchpoint Therapeutics has publicly launched with $70 million in series A financing and an earlier $30 million in seed money to develop covalent drugs for immune diseases. Its founders include ...

AM PSTElizabethan D - Private Company Track; Westin St. Francis Hotel, San Francisco, CAEMERYVILLE, Calif., Jan.